274 related articles for article (PubMed ID: 17279100)
1. Gene therapy progress and prospects: RNA aptamers.
Que-Gewirth NS; Sullenger BA
Gene Ther; 2007 Feb; 14(4):283-91. PubMed ID: 17279100
[TBL] [Abstract][Full Text] [Related]
2. The development and testing of aptamers for cancer.
Barbas AS; White RR
Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
[TBL] [Abstract][Full Text] [Related]
3. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
Stoltenburg R; Reinemann C; Strehlitz B
Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
[TBL] [Abstract][Full Text] [Related]
4. Complex target SELEX.
Shamah SM; Healy JM; Cload ST
Acc Chem Res; 2008 Jan; 41(1):130-8. PubMed ID: 18193823
[TBL] [Abstract][Full Text] [Related]
5. Locked nucleic acid aptamers.
Barciszewski J; Medgaard M; Koch T; Kurreck J; Erdmann VA
Methods Mol Biol; 2009; 535():165-86. PubMed ID: 19377996
[TBL] [Abstract][Full Text] [Related]
6. Aptamers: from bench side research towards patented molecules with therapeutic applications.
Majumder P; Gomes KN; Ulrich H
Expert Opin Ther Pat; 2009 Nov; 19(11):1603-13. PubMed ID: 19852719
[TBL] [Abstract][Full Text] [Related]
7. Nucleic acid aptamers as tools and drugs: recent developments.
Rimmele M
Chembiochem; 2003 Oct; 4(10):963-71. PubMed ID: 14523912
[TBL] [Abstract][Full Text] [Related]
8. Aptamers--basic research, drug development, and clinical applications.
Proske D; Blank M; Buhmann R; Resch A
Appl Microbiol Biotechnol; 2005 Dec; 69(4):367-74. PubMed ID: 16283295
[TBL] [Abstract][Full Text] [Related]
9. The future of aptamers in medicine.
Khati M
J Clin Pathol; 2010 Jun; 63(6):480-7. PubMed ID: 20360137
[TBL] [Abstract][Full Text] [Related]
10. Aptamers as tools for target validation.
Blank M; Blind M
Curr Opin Chem Biol; 2005 Aug; 9(4):336-42. PubMed ID: 16006181
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of aptamers for therapeutic studies.
Wochner A; Menger M; Rimmele M
Expert Opin Drug Discov; 2007 Sep; 2(9):1205-24. PubMed ID: 23496129
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology and aptamers: applications in drug delivery.
Levy-Nissenbaum E; Radovic-Moreno AF; Wang AZ; Langer R; Farokhzad OC
Trends Biotechnol; 2008 Aug; 26(8):442-9. PubMed ID: 18571753
[TBL] [Abstract][Full Text] [Related]
13. [Aptamers: selection and scope of applications].
Chauveau F; Pestourie C; Tavitian B
Pathol Biol (Paris); 2006 May; 54(4):251-8. PubMed ID: 16678359
[TBL] [Abstract][Full Text] [Related]
14. Systematic investigation of optimal aptamer immobilization for protein-microarray applications.
Walter JG; Kökpinar O; Friehs K; Stahl F; Scheper T
Anal Chem; 2008 Oct; 80(19):7372-8. PubMed ID: 18729475
[TBL] [Abstract][Full Text] [Related]
15. [Aptamers in clinical diagnostics].
Szpechciński A; Grzanka A
Postepy Biochem; 2006; 52(3):260-70. PubMed ID: 17201061
[TBL] [Abstract][Full Text] [Related]
16. Aptamers and riboswitches: perspectives in biotechnology.
Weigand JE; Suess B
Appl Microbiol Biotechnol; 2009 Nov; 85(2):229-36. PubMed ID: 19756582
[TBL] [Abstract][Full Text] [Related]
17. Targeting cancer cells with nucleic acid aptamers.
Cerchia L; de Franciscis V
Trends Biotechnol; 2010 Oct; 28(10):517-25. PubMed ID: 20719399
[TBL] [Abstract][Full Text] [Related]
18. Aptamers against extracellular targets for in vivo applications.
Pestourie C; Tavitian B; Duconge F
Biochimie; 2005; 87(9-10):921-30. PubMed ID: 15963620
[TBL] [Abstract][Full Text] [Related]
19. Aptamers: the emerging class of future anticoagulation for vascular disease.
Kuliczkowski W; Floyd J; Malinin A; Serebruany V
Expert Rev Cardiovasc Ther; 2010 Apr; 8(4):503-7. PubMed ID: 20397824
[TBL] [Abstract][Full Text] [Related]
20. Advances in SELEX and application of aptamers in the central nervous system.
Yang Y; Yang D; Schluesener HJ; Zhang Z
Biomol Eng; 2007 Dec; 24(6):583-92. PubMed ID: 17681489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
